Carle Vanessa 4
4 · Lexaria Bioscience Corp. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Carle Vanessa
Secretary
Transactions
- Purchase
common shares
2025-07-29$0.91/sh+750$683→ 750 total
Holdings
- 75,000
Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (15,000 underlying) - 27,500
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying) - 40,000
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying) - 17,500
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 60,000
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (10,000 underlying) - 12,500
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying) - 50,000
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (10,000 underlying)